skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Greetings,

Is the sell off in NOVO Nordisk warranted? Seems a bit harsh me thinks.

Just when the stock was pulling out of a tax loss selling nose dive, it now seems to have run out of gas and is falling again.

1) Should we view such a steep drop as possibly an over reaction? Should we wait to see if a bottom forms before stepping in? Buy, sell or hold?

2) I know 5i favours Eli Lilly but has most of the growth already taken place or do you predict even higher altitudes? Buy now or wait for a dip?

Cheers
A

Read Answer Asked by Arzoo on February 06, 2026
Q: As of today do you consider each of these a buy/hold /sell?
Would you start a new position in any of these or wait till the market settles somewhat?
Read Answer Asked by John on February 05, 2026
Q: Hi, Sorry there are lot of companies listed but in summary this is three part question:

1. I have BAM2%,BN9%,BEP5%. I was thinking of putting new money to KKR or BX or APO. Should i add new money to existing positions or to new positions. Which one and approx. price please.

2. All the listed are in red in various taxable and registered accounts. Which one is good candidate for new money , which one would be sell and hold.

3. ISRG is at 1.5%. Should i go to 5% in one shot or go slowly or just hold on . This is in taxable account.

Thanks
Read Answer Asked by S on February 05, 2026
Q: Good morning Peter and Team,

Something I've always wondered: Do negative news items about the founder of a particular company — Microsoft in this case — have any effect on the performance of the stock? Last night on the news, I heard Melinda Gates talk about her ex-husband's apparent relationship with Epstein, certainly not helping Bill's image.

Or are these stories just “noise” and should be ignored?
Read Answer Asked by Jerry on February 05, 2026
Q: Hello Team 5i,

Apart from the immense spending MSFT is continuing to undertake to beef-up their Azure capabilities can you comment :
(1).On the other reasons the shares have been severely punished since coming up with what appeared to be some reasonably good earnings for the past quarter? Also can you please explain :
(2). Why less than a few months ago MSFT renegotiation of their new terms with Open AI was heralded as a very good move (their stock value popped up the same day close to a new maximum) whereas the same relationship now seems to have become detrimental to MSFT, maybe even compounding their precipitous share price drop (from 550 to 410) among other reasons?. As always thank for sharing your always very good insights. Adel
Read Answer Asked by ADEL on February 05, 2026
Q: Keeping current market conditions in mind and assuming we still have more downside to come, can you share 5 US and 5 Canadian stocks/ETFs on your shopping list? I'm not worried about diversification - just looking for your top picks regardless of sector overlap.

Thank you!
Read Answer Asked by Gurdeep on February 05, 2026
Q: Hi There. Please correct me if I am wrong but I understand that Google, Microsoft and Amazon are stake holders of Anthropic. Can you please tell how much % ownership they have in Anthropic? Do you think this is a reasonable way of getting exposure to Anthropic? If yes, which stock if any would you purchase? Many thanks.
Read Answer Asked by Ian on February 05, 2026
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!